ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Morepen Laboratories has invested Rs. 20 Crore via a rights issue in its wholly-owned subsidiary, Morepen RX Limited, to strengthen its capital base.
Morepen Laboratories transferred a 9% stake in subsidiary Morepen Medipath to its Medical Devices head. The subsidiary remains consolidated despite the parent's stake reducing to 51%.
Morepen Laboratories transferred a 9% stake in its subsidiary, MML, to Mr. Anubhav Suri. The company retains control with a 51% majority shareholding.